Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Issues Quarterly Earnings Results

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) issued its earnings results on Friday. The company reported $0.16 earnings per share for the quarter, Zacks reports. Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 11.95%.

Shionogi & Co., Ltd. Trading Up 1.4 %

SGIOY traded up $0.10 on Friday, hitting $7.42. 98,808 shares of the company’s stock were exchanged, compared to its average volume of 218,618. The stock has a fifty day moving average of $7.07 and a two-hundred day moving average of $8.59. Shionogi & Co., Ltd. has a twelve month low of $6.22 and a twelve month high of $9.11. The firm has a market cap of $12.62 billion, a PE ratio of 12.65, a P/E/G ratio of 2.39 and a beta of 0.21.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.